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In previous experiments a new type of percutaneous device for implantation in soft tissue was 
designed, containing a sintered titanium fibre mesh. The devices are inserted by a so-called ‘two- 
phase’ surgical technique with an intervening healing period of 3 months between insertion of the 
subcutaneous and percutaneous parts. From a clinical point of view, this time interval is too long. The 
aim of this study was to investigate whether it was possible to reduce the intervening healing period. 
The implants were inserted in the backs of nine goats. In each goat, six implants were placed with 
intervals of 1 week. Consequently, at the end of the experiment, in each goat six implants were 
present with implantation periods ranging from 1 to 6 weeks. After 6 weeks, the animals were killed 
and the implants with surrounding tissue were processed histologically. Analysis demonstrated that 
during the first 2 weeks an inflammatory response was present. Thereafter, no difference in tissue 
response was found between the various implantation periods. In conclusion, the experiment 
suggests that for titanium mesh percutaneous devices a 3-week healing period is sufficient between 
the installation of the subcutaneous and percutaneous parts. ©  1996 Elsevier Science Limited
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It is well known that considerable difficulties exist with 
the maintenance of percutaneous devices1“9. The 
problems encountered are mainly concerned with exit- 
site infections and related complications.
Therefore, in our laboratory research has been 
directed toward the development of a more successful 
percutaneous device10“14. These efforts have resulted 
in a percutaneous device provided with a subcutaneous 
flange made of a porous titanium fibre mesh 
structure15. In addition to the design of the implant, a 
so-called two-stage surgical procedure was used for 
placement of the devices. During the first surgical 
session the subcutaneous component was inserted. 
After a healing period of 3 months the percutaneous 
part of the implant was adapted to the subcutaneous 
component. Because this healing period of 3 months 
was considered to be too long for application in 
peritoneal dialysis, an experiment has been performed 
to determine whether it is possible to reduce this 
period18. For this purpose, titanium fibre meshes were 
inserted subcutaneously in rabbits with implantation 
periods ranging from 5 to 12 weeks. Histological and 
histomophometrical analysis of the tissue response to 
the implants showed that there was no difference 
between the various implantation periods. Considering 
these results, further reduction of the healing period
Correspondence to Dr J.A. Jansen.
has to be evaluated. The purpose of this experiment 
was to analyse the tissue response to the titanium fibre 
structures with implantation periods varying from 1 to 
6 weeks.
MATERIAL AND METHODS
Implant materials
Figure 1 shows the porous fibre 
experiment. The mesh was fabricated by mtarengaging 
and intertwining a multiplicity of commercially pure 
titanium fibres (Bekaert, Belgium). After compression 
the fibre structures were sintered to bond 
their points of contact. The fibre diameter was 50 pan. 
The volumetric porosity was 86% and the weight of 
the mesh sheet was 600 gm 2. Scanning electron 
microscopical examination revealed on the surface of 
the titanium fibres the presence of irregular, rather
profound longitudinal As demonstrated
energy dispersive spectroscopic analysis, the surface of 
the fibres was composed of titanium .
Implantation procedure
Nine healthy, adult (2-3 years of age), female 
goats weighing about 60 kg ’ ’
experiments. In each goat, six implants
were used
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Figure 1
ment.
Titanium fibre mesh implant used in the experi-
three on the left and three on the right side of the spinal 
column. The implants measured 2 .0 x l .5 c m 2. The 
implants were inserted with intervals of 1 week. 
Consequently, at the end of the experiment, in each 
goat six implants were present, with implantation 
periods ranging from 1 to 6 weeks.
Before insertion the implants were sterilized in an 
autoclave. Surgery was performed under local 
anaesthesia. The back of the goats was shaved, washed 
and disinfected with iodine. Paravertebrally, only on 
one side of the spinal column, a longitudinal incision 
of about 3.0 cm was made through the full thickness of 
the skin. Subsequently, lateral to the incision a 
subcutaneous pocket was created by blunt dissection 
with scissors. The fibre mesh was inserted in this 
pocket. Finally, the wound was carefully closed with 
vicryl 3-0.
To assure complete randomization, the position of 
the various implants into the back was based on a split 
plot design14. Balancing was done by Latin square to
exclude experimental influences. The experimental 
protocol used for these studies was approved by the 
Institutional Animal Care and Use Committee and 
adhered to the National Institutes of Health guidelines 
for the use of experimental animals.
Histological evaluation techniques
One week after the last surgical procedure the animals 
were killed using an overdose of Nembutal(KJ. After the 
animals were killed, the implants with their 
surrounding tissues were excised immediately and 
fixed in 10% buffered formalin. The tissue specimens 
were then trimmed to remove excess tissue and 
embedded in methyl methacrylate. After polymeriza­
tion, thin (10 fim) histological sections were prepared 
using a modified diamond-blade sawing microtome 
technique18,19. The sections, containing the implants 
and the surrounding tissues attached to them, were 
stained with Methylene Blue and basic fuchsin and 
investigated by light microscopy.
To assess the soft tissue response to the implants, 
both histological and histomorphometric evaluations 
were performed. The histological evaluation consisted 
of a thorough description of the observed tissue 
reaction. For the histomorphometric evaluation the 
following parameters were assessed:
1. The characteristics of the capsule surrounding the 
implant and the characteristics of the tissue inside 
the interstices of the implant as rated according to 
a method that has already been described 
extensively in a previous paper (Table l)17. In 
summary, the evaluation of the interstitial tissue 
was only qualitative. The semiquantitative capsule 
classification consisted of a capsule thickness 
measurement based on the observed number of 
fibroblasts. The qualitative rating of the capsule 
and interstitium consisted of numerically rating the 
tissue morphology (fibrous tissue, maturity,
Table 1 Histological grading scale for soft-tissue implants
Reaction zone Response Score
thickness rating:
Capsule quantitatively 1-4 fibroblasts 4
5-9 fibroblasts 3
10-30 fibroblasts 2
> 30 fibroblasts 1
Not applicable 0
Capsule qualitatively capsule tissue is fibrous, mature, not dense, resembling connective 4
or fat tissue In the non-lnjured regions 
capsule tissue Is fibrous but immature, showing fibroblasts and little 3
collagen
capsule tissue Is granulous and dense, containing both fibroblasts and 2
many Inflammatory cells 
capsule consists of masses of inflammatory cells with little or no signs 1
of connective tissue organization 
cannot be evaluated because of infection or other factors not necessarily 0
related to the material
Interstitium qualitatively tissue in interstitium is fibrous, mature, not dense, resembling 4
connective or fat tissue in the non-injured regions 
tissue in interstitium shows blood vessels and young fibroblasts 3
invading the spaces; few macrophages may be present 
tissue in interstitium shows giant cells and other inflammatory cells in 2
abundance but connective tissue components in between 
tissue in interstitium is dense and exclusively of the inflammatory type 1
implant cannot be evaluated because of problems that may not be 0
related only to the material to be tested
Biomaterials 1997, Vol. 18 No. 2
Wound healing phenomena in titanium fibre mesh: Y.C.G.J. Paquay e ta i. 163
•  .  »mterstitium
capsule
• y - . v . v . v . v  v . v . »
• • ...................« '  I •  • • I ' I <
f  ^ . *• * . '   ^ « * *• » .  • I ► * s 
> S I * * 1 4 1  •>  .
? I • , - , . 4 9 . ' . . .  Ì -*» * * • •• • .W ,>  '  • V  l.V
V  ’ ,* * V  V  . * ’ v ’ r '  V
> i4 » \  ' * . < '  £ > r ; i I • , > I »
• A v * v , ' . v , y . , v . \ v v• fc n . ,  t, s field of measurement
field of measurement
Figure 2 Schematic drawing of the subcutaneous Implant 
showing the fields of cell counting used in the histomorpho- 
metric analysis.
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Figure 3 At 1 week implantation, the capsule surrounding 
the titanium fibre mesh consists mainly of inflammatory 
cells and blood vessels. Original magnification x25, 
bar=  122 ¿¿m.
|J»V.
presence of connective tissue or fat tissue) and 
cellularity (presence of fibroblasts, macrophages 
and giant cells).
2. The tissue response as quantified by counting the 
number of blood vessels and inflammatory/foreign 
body cells in the surrounding fibrous capsule and 
interstitial tissue. For this purpose, the microscopic 
images were projected with a total magnification of 
x400 on a colour monitor using a colour camera 
attached to the light microscope. Subsequently, the 
occurrence of blood vessels and foreign body giant
cells was calculated in 14 predetermined fields
(.Figure 2). Depending on the total length of the 
section, the fields were positioned at regular 2-mm 
intervals: six fields (with one side bordering the 
implant surface) in the capsule surrounding the 
fibre mesh, six in the middle of the interstitium 
and two at both ends of the interstitium. The 
occurrence of inflammatory cells in each field was 
estimated by superimposing a net ruling, consisting 
of 176 smaller squares (1.5 x 1.5 cm2) on the colour 
monitor. Then, the number of inflammatory cells in 
five marked squares per field was counted.
All histomorphometric procedures were done blindly 
by two different operators. Differences in scores were 
discussed. The data presented are based on ‘consensus 
between observers’ about the differing judgements.
RESULTS
Tissue response
Descriptive light microscopic evaluation 
Evaluation of the prepared sections showed that the 
tissue reaction to the titanium meshes with an 
implantation period of 1 week was mainly character­
ized by an inflammatory response. The implants were 
surrounded by a thick layer of inflammatory cells and 
blood vessels (Figure 3). Inside the porosity of the 
mesh mainly inflammatory cells were observed, 
although some fibroblasts were also present (Figure 4). 
Occasionally, accumulations of erythrocytes were 
found inside the mesh. Already at 2 weeks of implanta­
tion the inflammatory response around the mesh, as
Figure 4 Inside the porosity of the mesh, Inflammatory 
cells and blood vessels are present after 1 week implanta­
tion. Original magnification x63, bar = 49/im.
well as in the interstitium, decreased. The inflamma­
tory layer surrounding the implants was almost totally 
replaced by a fibrous tissue capsule consisting of 
fibroblasts and collagen. Also inside the mesh a cellular 
fibrous tissue was now present. Furthermore, the 
thickness of the reactive tissue capsule was less 
compared with the inflammatory cell layer surrounding 
the 1-week specimens.
The tissue response to the fibre meshes with an 
implantation period of 3-6 weeks was relatively 
uniform (Figure 5). These implants were surrounded 
by a medium thin fibrous tissue capsule containing 
fibroblasts, collagen, blood vessels and some inflamma­
tory cells. Occasionally, nerve bundles were observed 
close to the mesh material. Inside the implants, the 
mesh porosity was filled with components of early- 
stage connective tissue, including blood vessels 
{Figure 6).
Histomorphometric evaluation
Figure 7 shows the data of the histomorphometric 
rating of capsule and interstitium characteristics for all 
implantation periods. Statistical analysis of these data, 
using a one-way analysis of variance (ANOVA) and a 
multiple comparison procedure (Newman-Keuls), 
showed that a significant difference existed in capsule
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Figure 5 After 2 weeks implantation, the tissue capsule 
consists mainly of fibroblasts and collagen. The inflamma­
tory response, together with the number of blood vessels, 
decreased. Original magnification x25, bar =  122¿¿m.
Figure 6 Inside the mesh material early stage connective 
tissue is present at 3 weeks implantation. Original magnifi­
cation x63, bar =  49/im.
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Figure 7 Comparative rating of capsule quantity, capsule 
quality and interstitium quality using the histomorphometric 
grading scale.
quantity between 1-week and 3-6-week implants 
(P < 0.01). In addition, a significant difference was 
demonstrated in capsule and interstitium quality 
between 1-week and 2-6-week specimens [P < 0.01 in 
both cases.
Figure 8 provides data on the occurrence of 
inflammatory and foreign body giant cells, as well as 
blood vessels, in the fibrous capsule and interstitial
1 week 3 weeks 5 weeks
2 weeks 4 weeks 6 weeks
Figure 8
6375 /i m2;
Comparative rating of: a, inflammatory
2; c,b, foreign body giant cel Is/224 310/^m 
vessels/224 310/im 2.
cells/
blood
tissue. One-way ANOVA and a multiple comparison 
procedure (Newman-Keuls) indicated that a significant 
difference existed in the number of inflammatory cells 
occurring in the middle of the interstitial tissue 
between an implantation period of 1 week compared 
to 3-6 weeks (P < 0.01).
For all implantation periods, no foreign body giant 
cells were found in the fibrous capsule. Although it 
appeared that at 1 week of implantation less giant cells 
were present in the interstitium, no significant 
difference in foreign body giant cell occurrence existed 
for the various implantation periods.
Statistical analysis of the blood vessel data revealed 
that there was no significant influence of the implanta-
Biomaterials 1997, Vol. 18 No. 2
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tion period on the number of blood vessels in both 
capsule and interstitium. The diameter of the blood 
vessels varied from 5 to 100 /an.
Finally, the number of inflammatory cells, foreign 
body giant cells and blood vessels present in the
mesh material the
endings of the interstitium was not significantly 
different.
DISCUSSION AND CONCLUSIONS
The success of implanted biomaterials is dependent on 
many factors, which all have to do with the final tissue 
response to the materials. In the cascade of events that 
follow after the first injury to insert a material, the 
duration and level of the initial inflammatory response 
play an important role. With regard to the implant 
material used, the possibility of evoking an adverse 
healing response depends on material variables like
bulk chemistry, 
design20,21.
surface texture and
For example, in another
implant 
study9 we
compared in goats the subcutaneous tissue reaction to
implants
Dacron®
provided with either the currently used 
velour versus titanium fibre mesh. Four 
months after implantation, histological and histomor- 
phometrical evaluation showed that the soft tissue 
response inside the Dacron velour was mainly 
inflammatory, while inside the porosity of the titanium 
mesh a more mature collagenous tissue was found. In 
this context, it has to be emphasized that titanium is 
considered to be a very biocompatible material22. 
Therefore, it is not surprising that the overall healing 
process to the titanium fibre mesh, as used in this 
study, shows a striking similarity to the regular
connective tissue wound healing 
Although the exact time depends on 
the original tissue location, the initial inflammatory 
and proliferative phase of wound healing takes about 2 
weeks, followed by a remodelling phase. The histomor- 
phometric evaluation of the soft tissue response to the 
titanium fibre mesh material, as used in the present 
study, showed that during the first 2 weeks after 
implantation a tissue response occurred resembling an 
early tissue reaction characteristic for a surgical 
trauma without an implant26. When this response 
faded away, which was generally after no longer than 
2-3 weeks, fibroblasts started to proliferate. This was 
followed by the deposition of collagen inside the
sequence in all 
processes23-25.
titanium mesh. Unfortunately, the histological
preparation technique used makes it impossible to 
obtain additional information about the quality of the
collagen matrix produced.
Considering our previous study in rabbits16, dealing 
with the healing response between 5 and 10 weeks, we 
now observed no difference between the number of 
foreign body giant cells as found in the end and the 
middle parts of the interstitium. Two explanations can 
be given for this discrepancy in observations. First, it 
is possible that the implantation period is too short to 
result in a different reaction, certainly when it is 
recognized that mechanical trauma, as a product of the 
flexibility properties of the implant, is responsible for 
the adverse reaction at the ends of the mesh 
implants26,27. Second, the implantation site as used in 
this study in goat is more flattened than in the previous
study in rabbit, consequently resulting in less 
mechanical trauma.
Finally, comparison of our studies in goat and rabbit 
shows that with the applied histomorphometrical 
techniques no gross differences can be demonstrated 
between the 3-6 and 5-10 week healing periods.
Therefore, on the basis of the results we assume that 
the intervening healing period between the first and 
second stage surgical procedure for placement of our 
experimental titanium mesh percutaneous device can 
be reduced to 3 weeks. This observation can lead to a 
better clinical acceptance of this device for human 
applications like peritoneal dialysis, although it has to 
be emphasized that extrapolation of experimental 
animal results to the human situation is not always 
straightforward.
ACKNOWLEDGEMENT
These investigations were supported 
Netherlands Technology Foundation (STW).
by the
REFERENCES
i
2
3
4
5
6
7
8
9
10
11
12
13
Moncrief JW, Popovich RP. Continuous ambulatory 
peritoneal dialysis (CAPD). In: Nolph KD, ed. Peritoneal 
Dialysis. Dordrecht, The Netherlands: Kluwer 
Academic, 1988:152-168.
Paquay YCGJ, Jansen JA, Goris RJA, Hoitsma AJ. Long­
term clinical experience with continuous ambulatory 
peritoneal dialysis: access related problems, J Invest 
Surg 1996; 9: 81-93.
Schreuders PD, Salthouse TN, von Recum AF. Normal 
wound healing compared to healing within porous 
Dacron implants. /  Biomed Mater Res 1988; 22: 121. 
Gangjee T, Colaizzo R, von Recum AF. Species-related 
differences in percutaneous wound healing. Ann 
Biomed Eng 1985; 13: 451.
von Recum AF. Applications and failure modes of 
percutaneous devices: a review. ƒ Biomed Mater Res 
1984; 18: 323.
Yan JYJ, Cooke, FW, Vaskelis PS, von Recum AF. 
Titanium-coated Dacron1“' velour: a study of interfacial 
connective tissue formation, ƒ Biomed Mater Res 1989; 
23: 171.
Feldman DS, Hultman SM, Colaizzo RS, von Recum AF. 
Electron microscope investigation of soft tissue 
ingrowth into Dacron110 velour with dogs. Biomaterials 
1983; 4: 105.
Feldman DS, von Recum AF. Non-epidermally induced 
failure modes of percutaneous devices. Biomaterials 
1985; 6: 352.
Paquay YCGJ, de Ruijter JE, van der Waerden JPCM, 
Jansen JA. Tissue reaction to Dacron'"' velour and 
titanium fibre mesh used for anchorage of percutaneous 
devices. Biomaterials 1996; 17: 1251.
Jansen JA, de Groot K. Guinea pig and rabbit model for 
the histological evaluation of permanent percutaneous 
implants. Biomaterials 1988; 9: 268.
Jansen JA, van der Waerden JPCM, van der Lubbe HBM, 
de Groot K. Tissue response to percutaneous implants 
in rabbits. ƒ Biomed Mater Res 1990; 24: 295.
Jansen JA, van der Waerden JPCM, de Groot K. Wound- 
healing phenomena around percutaneous devices 
implanted in rabbits. J Mater Sci: Mater Med 1990; 1: 
192.
Jansen JA, van der Waerden JPCM, de Groot K. Develop-
MM
Biomaterials 1997, Vol. 18 No. 2
1 6 6 Wound healing phenomena in titanium fibre mesh: Y.C.G.J. Paquay et al.
14
15
16
17
18
ment of a new percutaneous access device for implanta­
tion in soft tissues. ƒ Biomed Mater Res 1991; 25: 1535. 
Jansen JA, Paquay YCGJ, van der Waerden JPCM. Tissue 
reaction to soft-tissue anchored percutaneous implants 
in rabbits. /  Biomed Mater Res 1994; 28:1047. 
Ducheyne P, Martens M, de Meester P, Muliier JC. 
Titanium implants with porous structures for bone 
ingrowth: a general approach. In: Titanium Alloys in 
Surgical Implants, ASTM STP 796. Philadelphia: 
American Society for Testing and Materials, 1983: 
265-279.
Paquay YCGJ, de Ruijter JE, van der Waerden JPCM, 
Jansen JA. Titanium fiber mesh anchorage for percut­
aneous devices applicable for peritoneal dialysis, ƒ 
Biomed Mater Res 1994; 28:1321.
Jansen JA, von Recum AF, van der Waerden JPCM, de 
Groot K. Soft tissue response to different types of 
sintered metal fibre-web materials. Biomaterials 1992;
13: 959.
Van der Lubbe HBM, Klein CAPT, de Groot K. A simple 
method for preparing thin (10 /tm) histological sections 
of undecalcified plastic embedded bone with implants. 
Stain Technol 1988; 63:171.
19
2 0
2 1
2 2
23
24
25
26
27
Klein CAPT, Sauren YMHF, Modderman WE, van der 
Waerden JPCM. A new saw technique improves 
preparation of bone sections for light and electron 
microscopy. J Appl Biomater 1994; 5: 369.
Williams DF, ed. Biocompatibility: an overview. In: 
Concise Encyclopedia of Medical & Dental Materials. 
Oxford: Pergamon Press, 1990: 51-59.
Black J, ed. Biocompatibility: definitions and issues. In: 
Biological Performance of Materials: Fundamentals of 
Biocompatibility. New York: Marcel Dekker, 1992: 3-9. 
Steinmann SG, Mäusli P-A. Titanium alloys for surgical 
implants— biocompatibility from physicochemical 
principles. Sixth World Conference on Titanium, 1988. 
Wokalek H. Cellular events in wound healing. CRC Crit 
Rev Bioeng 1988; 4: 209.
Silver IA. The physiology of wound healing. Schweiz 
Rundschau Med 1984; 43: 942.
Ross R. Wound healing. ScientAm 1969; 220: 40. 
Spector M, Cease C. Tong-Li X. The local tissue 
response to biomaterials. CRC Crit Rev Bioeng 1989; 5: 
269.
Heimke G. Percutaneous implants. Adv Mater 1991; 3: 
108.
I
Biomaterials 1997, Vol. 18 No. 2
